- Report
- November 2021
- 747 Pages
Global
From €3885EUR$4,000USD£3,351GBP
- Report
- November 2021
- 392 Pages
Global
From €2914EUR$3,000USD£2,514GBP
- Report
- November 2021
- 280 Pages
Global
From €2720EUR$2,800USD£2,346GBP
- Report
- June 2023
- 236 Pages
Global
From €5565EUR$5,730USD£4,801GBP
- Report
- August 2022
- 210 Pages
Global
From €5565EUR$5,730USD£4,801GBP
- Report
- December 2021
- 190 Pages
Global
From €5991EUR$6,168USD£5,168GBP
- Book
- August 2021
- 208 Pages
- Book
- April 2018
- 312 Pages
- Book
- February 2023
- 576 Pages
- Book
- December 2022
- 464 Pages
- Book
- December 2021
- 576 Pages
- Book
- October 2019
- 472 Pages
- Book
- July 2015
- 384 Pages
- Book
- January 2013
- 632 Pages
- Book
- May 2012
- 528 Pages
The Liposome market is a subset of the Drug Delivery market, which focuses on the development of technologies to deliver drugs to their intended targets. Liposomes are microscopic vesicles composed of phospholipids, which are used to encapsulate drugs and deliver them to the desired location in the body. Liposomes are advantageous due to their ability to protect drugs from degradation, increase drug solubility, and target specific cells.
Liposome-based drug delivery systems are used in a variety of therapeutic areas, including oncology, infectious diseases, and cardiovascular diseases. Liposomes are also used in the development of vaccines, as they can be used to deliver antigens to the body and induce an immune response.
Notable companies in the Liposome market include Lipoxen Technologies, Lipomed, and Liposome Company. Other companies in the market include Avanti Polar Lipids, Bio-Techne, and InnoBio. Show Less Read more
